MedPath

Evaluation of N-acetyl cysteine mouth wash as a new treatment approach for gingivitis

Phase 2
Completed
Conditions
Gingivitis
Oral Health
Registration Number
ISRCTN31352091
Lead Sponsor
niversity of Science and Technology
Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30673864

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Healthy gingiva with no evidence of periodontitis
2. Male and females aged between 18 to 28
3. Willing to participate and comply with the objectives of the study

Exclusion Criteria

1. Regular users of antiplaque rinses or the use of oral rinses for 30 days before baseline
2. Antibiotics intake within the previous 2 months
3. Smokers
4. Pregnancy or lactation
5. Systemic diseases or long term medications that influencing gingival conditions
6. Orthodontic appliance
7. Presence of detectable increased attachment loss
8. Chewing khat (flowering plant native to the Horn of Africa and the Arabian Peninsula)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bacteria in sub-gingival plaque is measured using bacteria samples from the participants analyzed using DNA sequencing at baseline and day 21 and 35.
Secondary Outcome Measures
NameTimeMethod
<br> For the preventative and treatment stages:<br> 1. Plaque is measured using an index scoring system from 0-3 at baseline and at day 7, 14, 21, 28 and 35<br> 2. Gingival index is measured using an index scoring system from 0-3 at baseline and at day 7, 14, 21, 28 and 35<br> 3. Papilla bleeding is measured using an index scoring system from 1-4 at baseline and at day 7, 14, 21, 28 and 35<br>
© Copyright 2025. All Rights Reserved by MedPath